Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.
Tseng JS, Wang CL, Huang MS, Chen CY, Chang CY, Yang TY, Tsai CR, Chen KC, Hsu KH, Tsai MH, Yu SL, Su KY, Wu CW, Yang CT, Chen YM, Chang GC.
Tseng JS, et al. Among authors: tsai mh, tsai cr.
PLoS One. 2014 Sep 12;9(9):e107160. doi: 10.1371/journal.pone.0107160. eCollection 2014.
PLoS One. 2014.
PMID: 25215536
Free PMC article.